Are peptides legal in Wyoming?

Can a Wyoming resident get peptides by telehealth?

Wyoming Statutes section 33-26-102(a)(xxix) defines telemedicine as the practice of medicine by electronic communication or other means from a physician in one location to a patient in another, with or without an intervening provider, and section 33-26-202 authorizes the Wyoming Board of Medicine to adopt telemedicine rules. Because telemedicine is the practice of medicine, the physician generally needs a Wyoming license. Board of Medicine rules chapter 1, section 7 (Exemption from licensure) carves out narrow exceptions: section 7(a) lets an out-of-state physician brought in for consultation by a Wyoming-licensed physician, in person or through telemedicine, practice for up to 12 days in any 52-week period after written notice to the Board; and section 7(e) lets an out-of-state physician or physician assistant who first saw a Wyoming resident in person in a state where they are licensed continue that care by telehealth for up to six months, after which another in-person visit is required, with new conditions referred to a Wyoming-licensed provider. Section 33-26-402 treats initially prescribing controlled substances over the internet without an established physician-patient relationship as grounds for discipline; GLP-1 medicines and the peptides in this database are not controlled. The Board of Medicine rules do not address whether an asynchronous encounter alone can support a new prescription, so this record leaves that question open. [3] [4] [7]

How does the Wyoming pharmacy board treat compounding?

The Wyoming State Board of Pharmacy licenses pharmacies under the Wyoming Pharmacy Act (Wyoming Statutes title 33, chapter 24) and the Board's rules. Section 33-24-152 requires a nonresident pharmacy that dispenses to Wyoming patients to hold a Wyoming license, stay licensed in its home state, keep readily retrievable records of controlled substances and dangerous drugs dispensed to Wyoming patients, comply with the Wyoming generic substitution requirements, and offer a toll-free pharmacist line at least six days and 40 hours a week; the Board may deny, suspend, or revoke the license and assess penalties of up to $2,000 per violation. Compounding is governed by chapter 22 (Compounding) of the Board's Pharmacy Act rules, effective August 19, 2025, which replaced the repealed chapter 13 (non-sterile compounding) and chapter 17 (sterile compounding). Chapter 22 applies to all licensees and adopts by reference USP-NF general chapters 795 (non-sterile), 797 (sterile), 800 (hazardous drugs), and 825 (radiopharmaceuticals) as minimum standards; a 2026 amendment proposed by the Board only fixes the reference date to USP-NF 2024, Issue 1 (official May 1, 2024). Chapter 22 does not set a state list of compoundable bulk substances, so a peptide's eligibility follows the federal 503A test (approved drug component, USP or NF monograph, or FDA 503A bulks list). [1] [2] [5] [6] [7] [8] [9]

Can you get compounded GLP-1s in Wyoming?

Because rural Wyoming patients often rely on mail order, the practical check is that the shipping pharmacy holds a Wyoming nonresident pharmacy license under section 33-24-152. [1] [8] [12]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Wyoming?

Find a provider in Wyoming

• Compounding pharmacies in Wyoming
• Clinics in Wyoming
• Telehealth providers in Wyoming

Is it legal to buy research peptides in Wyoming?

The Wyoming Pharmacy Act (title 33, chapter 24) limits dispensing of prescription drugs to licensed pharmacies, including licensed nonresident pharmacies, so a seller shipping "research use only" injectable peptides to Wyoming consumers is outside the licensed channel. [7] [13]

Peptide-specific notes for Wyoming

No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.

Frequently asked questions

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.